As-3
PrescriptionTicari adlar: AS-3
About This Medication
ADDITIVE SOLUTION FORMULA 3 (AS-3), 300 mL Each 100 mL contains: Citric Acid (Monohydrate), USP 0.042 g Monobasic Sodium Phosphate (Monohydrate), USP 0.276 g Sodium Chloride, USP 0.410 g Adenine, USP 0.030 g Dextrose (Anhydrous), USP 1.000 g Sodium Citrate (Dihydrate), USP 0.588 g containing 15 mEq of Sodium. . Description
Etken Maddeler
| Bileşen | Güç |
|---|---|
| Adenine | - |
| Dextrose, Unspecified Form | - |
Uyarılar ve Önlemler
Warnings and precoutions section See appropriate Operator’s Manual for additional information and complete usage instructions. Not for direct intravenous infusion Do not use unless solution is clear and no leaks detected Single use container. Discard unused portion Intended for use only with automated red cell washing and apheresis devices Store at room temperature. Avoid excessive heat. Protect from freezing
Frequently Asked Questions
Warnings and precoutions section See appropriate Operator’s Manual for additional information and complete usage instructions. Not for direct intravenous infusion Do not use unless solution is clear and no leaks detected Single use container. Discard unused portion Intended for use only with automated red cell washing and apheresis devices Store at room temperature. Avoid excessive heat. Protect from freezing
As-3 is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Injection Products
Browse all Injection products →References & Data Sources
- • DailyMed — As-3 drug label (National Library of Medicine)
- • openFDA — As-3 label data (U.S. Food & Drug Administration)
- • NDC Directory — As-3 (FDA National Drug Code)
Tıbbi Sorumluluk Reddi
Bu sayfadaki bilgiler yalnızca eğitim amaçlıdır ve profesyonel tıbbi tavsiye, teşhis veya tedavinin yerine geçmek amacıyla kullanılmamalıdır.
Bir tıbbi durum veya ilaçla ilgili sorularınız için her zaman doktorunuzun veya nitelikli başka bir sağlık uzmanının tavsiyesine başvurun.
Veri kaynakları: DailyMed (NLM), openFDA, MFDS